2027 Drug Hypersensitivity Research Grant
The 2027 Drug Hypersensitivity Research Grant from the American Academy of Allergy Asthma and Immunolog funds innovative research advancing knowledge of drug hypersensitivity, excluding vaccine reactions.
Funder: American Academy of Allergy Asthma and Immunolog
Due Dates: October 12, 2026: Application deadline (full application) for the 2027 Drug Hypersensitivity Research Grant — applications due by 3:00 pm CT
Funding Amounts: Up to three grants awarded; typical award size not specified; funds cannot be used for institutional indirect costs.
Summary: Supports innovative research to advance the understanding of drug hypersensitivity, excluding vaccine reactions.
Key Information: Applications focused on vaccine reactions are not eligible; indirect costs are not allowed.
Description
This grant opportunity, provided by the American Academy of Allergy Asthma and Immunolog (AAAAI), aims to support up to three research projects that significantly advance the state of knowledge in drug hypersensitivity. The program encourages the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on the field. Projects related to vaccine reactions are not eligible for this award. The initiative is designed to foster innovation and support researchers in allergy and immunology, particularly those aiming to develop independent research careers.
